CALB1 and nasopharyngeal carcinoma: In addition, intracerebroventricular treatment with G2-β-CD prevented the reduction of calbindin-positive cells in the cerebellum, a measure of Purkinje cells, body weight and motor dysfunction indicating that intracerebroventricular G2-β-CD treatment protects against central nervous system (CNS) damage in the NPC mouse model.